Spots Global Cancer Trial Database for A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Name: Laura Chow, MD

Affiliation: University of Washington

Role: PRINCIPAL_INVESTIGATOR

Name: Omid Hamid, MD

Affiliation: The Angeles Clinic

Role: PRINCIPAL_INVESTIGATOR

Name: Jhanelle Gray, MD

Affiliation: Moffitt Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Rachel Sanborn, MD

Affiliation: Providence Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Mohamad Salkeni, MD

Affiliation: Mary Babb Randolph Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Monika Joshi, MD

Affiliation: Penn State Hershey Cancer Institute

Role: PRINCIPAL_INVESTIGATOR

Name: Robert Alter, MD

Affiliation: John Theurer Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Raid Aljumaily, MD

Affiliation: Peggy Charles Stephenson Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Jason Chesney, MD

Affiliation: Brown Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Fernando Quevedo, MD

Affiliation: Mayo Clinic

Role: PRINCIPAL_INVESTIGATOR

Name: Martin Voss, MD

Affiliation: Memorial Sloan Kettering Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Johanna Bendell

Affiliation: SCRI Development Innovations, LLC

Role: PRINCIPAL_INVESTIGATOR

Name: Elizabeth Henry

Affiliation: Loyola Univ. Medical Center

Role: PRINCIPAL_INVESTIGATOR

Name: Lionel Lewis

Affiliation: Dartmouth-Hitchcock Medical Center

Role: PRINCIPAL_INVESTIGATOR

Name: Brian Rini

Affiliation: The Cleveland Clinic

Role: PRINCIPAL_INVESTIGATOR

Name: Peter Van Veldhuizen

Affiliation: Menorah Medical Center tour

Role: PRINCIPAL_INVESTIGATOR